Terms of Service

You must be at least 18. The Service is not directed to children under 18; we do not knowingly collect information from children under 13. You confirm legal capacity under your state's laws.

The Service is U.S.-only. Availability varies by state. The eligible-state list at https://sipra.com/states is part of these Terms by reference.

If you travel outside an eligible state, your physician may pause prescriptions until you return.

Use the Service only for yourself. Do not obtain a prescription for another person, except as a documented legal guardian where the patient is enrolled directly.

Give accurate, complete, current information at intake and during care, and update if it changes. False or incomplete health information can lead to inappropriate treatment and harm you.

Sipra is a technology and marketing platform. We do not practice medicine, dispense medications, or sell insurance. We coordinate care by routing intake to physicians at the affiliated medical practice, routing prescriptions to Healthcare Prosoft, LLC (operating the VSDH One Platform), Epiq Scripts LLC, Valiant Compounding Pharmacy, and Perfect RX, processing payments, and supporting you with messaging, scheduling, and education.

• Asynchronous intake review. You complete a questionnaire a physician reviews.
• Synchronous consult. When clinically indicated, a physician conducts a live phone or video visit.
• Ongoing messaging. Secure messaging with your care team during treatment.
• 24/7 medical support through the patient portal.

Some prescriptions are filled at 503A compounding pharmacies. Compounded medications are not FDA-approved for safety or effectiveness. They may be prescribed when commercially available FDA-approved drugs do not meet your specific needs.

Sipra is not affiliated with Eli Lilly, Novo Nordisk, or any other branded GLP-1 manufacturer, and does not market its compounded medications as "generic Ozempic," "generic Wegovy," "generic Mounjaro," "generic Zepbound," or any other Lilly or Novo Nordisk product. Compounded medications are independent formulations prepared by a state-licensed 503A pharmacy on a patient-specific prescription; they are not equivalents to FDA-approved branded products and are not "generic" in the FDA sense.

Treatment-specific safety information is in our https://sipra.com/safety (the ISI).

We can add, change, or remove parts of the Service any time, including individual treatments. If a treatment becomes unavailable due to clinical-supply or regulatory change, we refund any unshipped portion pro-rata under the Refund and Cancellation Policy. Material changes to clinically significant features are announced in the patient portal at least 30 days in advance, except where shorter notice is required for safety, regulatory, or supply reasons.

• Not a hospital, urgent-care center, or in-person clinic; we do not provide in-person care.
• Not an insurer, health plan, or TPA. Cash-pay only, see Section 4.3.
• Not a pharmacy. We coordinate with licensed 503A pharmacies that fill prescriptions from the physician network.
• Not a substitute for primary care. Keep seeing your primary care provider and tell them about treatment through the Service.
• Not a clinical-research sponsor. The Service is not a clinical trial; treatment is individualized standard-of-care prescribing.
• Not affiliated with Eli Lilly, Novo Nordisk, or any branded GLP-1 manufacturer; we do not market any product as a "generic" of a Lilly or Novo Nordisk drug.

We follow the FTC Endorsement Guides and FDA drug-promotion rules. We cite averages from peer-reviewed clinical trial data with a clear "Individual results vary" disclosure. We do not show before-and-after photos, do not promise specific weight-loss numbers, and do not call compounded GLP-1 products "generic" versions of Ozempic, Wegovy, Mounjaro, or Zepbound.

The following telehealth consent applies when you order laboratory testing, and you provide it by agreeing to these Terms at lab checkout:

I understand that Telehealth is a mode of delivering health care services via communication technologies (e.g., internet or cellphone) to facilitate diagnosis, consultation, treatment, education, care management, and self-management of a patient’s health care.

By acknowledging my consent below, I understand and agree to the following:

I understand that Junction and affiliate Openloop Healthcare Partners, PC offer Telehealth consultations, which are conducted through videoconferencing, telephonic, and asynchronous technology and my Telehealth provider will not be present in the room with me.

I understand there are potential risks to the use of Telehealth technology, including but not limited to, interruptions, delays, unauthorized access, and or other technical difficulties. I understand that either my Telehealth provider or I can discontinue the Telehealth appointment if the technical connections are not adequate for my visit.

I understand that I could seek an in-office visit rather than obtain care from a Telehealth provider, and I am choosing to participate in a Telehealth consultation with Junction, an affiliate of Openloop Healthcare Partners, PC, Openloop Healthcare Partners, PC, Openloop Healthcare Partners California, PC, Openloop Healthcare Partners Colorado, PC, Openloop Healthcare Partners New Jersey, PC, Openloop Healthcare Partners Wisconsin SC, Reliant.MD Medical Associates, PLLC, Reliant.MD Medical Associates California, PC, Reliant.MD Medical Associates Colorado, PC, Reliant.MD Medical Associates New Jersey, PC, Reliant.MD Medical Associates Wisconsin, SC, MECNB Physician Services, PC, MECNB Physician Services California, PC, MECNB Physician Services Colorado, PC, MECNB Physician Services New Jersey, PC, and MECNB Physician Services, SC.

To protect the confidentiality of my health information, I agree to undertake my Telehealth consultation in a private location, and I understand that my Telehealth provider will similarly be in a private location.

I understand that I am responsible for payment of any amounts due and owing resulting from my Telehealth visit.

In an emergent situation, I understand that the responsibility of my Telehealth provider may be to direct me to emergency medical services, such as an emergency room.

By acknowledging below, I certify:

• that I have read this form and/or had it explained to me
• that I understand the risks and benefits of a Telehealth appointment
• That I have been given the opportunity to ask questions and that such questions have been answered to my satisfaction.

Create an account using your full legal name, date of birth, email, residential address, and phone. Your account is personal, do not share credentials.

We may verify your identity using a government ID and selfie or live photo. We do not extract or store biometric identifiers. ID images are retained only as long as needed for clinical eligibility and fraud control.

You are responsible for activity under your account. Email [email protected] immediately if you suspect unauthorized access. We may suspend or close accounts showing fraud or violation of these Terms.

By using the Service, you consent to receive contracts, notices, and disclosures electronically; your electronic signature has the same legal effect as a handwritten one. Withdrawing consent (closing your account) ends your access.

Sipra is the technology/marketing entity (MSO). The affiliated medical practice is the prescribing entity (PC). Sipra does not direct any physician's clinical decisions.

The affiliated medical practice is your healthcare provider and a HIPAA Covered Entity. Sipra LLC supports it as Business Associate. The practice's Notice of Privacy Practices is at https://sipra.com/hipaa-notice or on request via [email protected]. PHI use/disclosure is described there and in our https://sipra.com/privacy.

Sipra and the affiliated medical practice do not bill, accept, or coordinate with Medicare, Medicaid, TRICARE, or any federal or state healthcare program. Cash-pay only. Neither party pays the other based on volume or value of prescriptions. Intended to comply with the federal Anti-Kickback Statute (42 USC §1320a-7b(b)), Stark Law (42 USC §1395nn), and Eliminating Kickbacks in Recovery Act (18 USC §220).

Federal law requires drug/device manufacturers to publicly report payments and gifts to physicians. Payments to your physician may be available at openpaymentsdata.cms.gov.

By default, your physician routes your prescription to a listed Sipra partner. You can request any licensed pharmacy; some may not stock compounded products, and your physician will discuss options.

Sipra and the affiliated medical practice earn no extra fees for steering prescriptions. Partners are selected on accreditation (PCAB or NABP), state licensure, fulfillment performance, and cost, not prescriber compensation.

If a pharmacy faces a back order, supply disruption, or compliance issue, we may transfer your prescription to another listed partner. We notify you in advance and identify the new pharmacy. You may decline by emailing [email protected] before processing; we'll work with you and your physician on an alternative, which may include pausing until your original pharmacy returns or you select a different licensed pharmacy. Current partners: https://sipra.com/pharmacy.

The Service is not for emergencies. Medical emergency: call 911. Mental health crisis: call or text 988 (988 Suicide & Crisis Lifeline). The Service is not a substitute for in-person, urgent, or hospital care.

No physician or Sipra employee is paid based on whether, what, how many, or what type of prescriptions are issued. Physician payments are based on time spent on intake review, consults, and follow-up.

At launch, Sipra offers two subscription tiers: a 1-Month plan at $300 per month and a 3-Month (Quarterly) plan at $250 per month, each recurring until paused or canceled. Each tier includes physician evaluation, prescription fulfillment when approved, and ongoing follow-up. Pricing varies by treatment category. Current pricing is published at https://sipra.com/pricing.

At checkout, total cost, billing cadence, renewal price, and cancellation method are disclosed above the pay button in plain language. We follow the FTC Negative Option Rule (16 CFR Part 425), Restore Online Shoppers' Confidence Act (15 USC §§8401-05), and applicable state auto-renewal laws (CA AB 2863, NY GBL §527-a, MA 940 CMR, OR HB 4032).

Sipra captures your card at intake but does not charge it until your clinician approves and prescribes. You may cancel without charge any time before clinician approval.

Each refill is subject to physician review and approval. Approximately 21 days before the end of your current paid period, we open a recurring check-in in your portal. You complete a brief check-in; your physician reviews your status and may approve the next refill, adjust your dose, or decline continuation. Your card is charged only when your physician approves the next refill. If your physician declines, you owe nothing for that cycle. If you have not completed your check-in by the deadline, your physician may review your existing record and either continue treatment at your prior dose, pause your subscription, or discontinue treatment. California, New York, Connecticut, and Colorado residents receive an annual subscription renewal notice consistent with applicable state law.

The 3-Month plan is a single up-front payment for the quarter. Medication ships in plan-sized tranches: 1-Month plans ship monthly; 3-Month plans ship the full quarter’s medication in one shipment after physician approval.

Cancel any time through your patient portal. To prevent your next refill from shipping, please cancel at least 13 calendar days before your physician’s next review (which begins approximately 10 days before the end of your current paid period). The 3 calendar days before each physician review are the cancel-lock window. Cancellations submitted during this window are still honored if your physician has not yet approved. Once approved and your card is charged, that shipment cannot be cancelled, but cancellation of all future cycles takes effect immediately.

Cancel through:

• patient portal (one click);
• any Sipra mobile app;
• email [email protected]; or
• the patient portal, or email [email protected].

No phone, menus, or retention call. Refund logic: https://sipra.com/refunds.

You can pause an active subscription up to 90 days and resume without re-doing intake. Paused subscriptions do not auto-renew.

Charges appear as SIPRA*HEALTH.

If paying by ACH or other EFT, you authorize Sipra to initiate recurring debits in the amount and on the cadence of your subscription. Revoke any time by canceling; revocation applies to the next billing cycle.

Nothing here waives your rights under the Truth in Lending Act (15 USC §1666), Electronic Fund Transfer Act, or your card network's chargeback rules. If a charge is in error, contact [email protected] first so we can resolve quickly.

We may change prices with 30+ days' email notice. To reject a new price, cancel before the next renewal.

You can pay with HSA or FSA cards if your plan allows. Sipra does not verify HSA/FSA eligibility. You are responsible for rejected or recovered payments.

Some platforms make patients waive credit-card chargeback rights. Sipra does not. You keep all chargeback rights under the Truth in Lending Act, Electronic Fund Transfer Act, and your card network's rules. Please contact [email protected] first so we can resolve without involving your bank. Sipra may suspend or terminate service for any customer who initiates a chargeback without first contacting [email protected].

Each subscription includes:

• clinical evaluation by a physician licensed in your state;
• up to 4 follow-up messages per month;
• medication shipped on the cadence in your treatment plan, when approved;
• 24/7 medical support line; and
• standard shipping in cooled packaging where required.

Lab work, additional consultations beyond included follow-ups, and add-on therapies are billed separately at Pricing-page rates.

By using the Service, you agree to receive communications electronically, email, in-app, push, and SMS. Electronic communications satisfy any legal "in writing" requirement.

Sipra uses two separate SMS types with separate consent. You can consent to one and decline the other.

(a) Transactional / service SMS. Account, care, and subscription messages, appointment reminders, intake follow-ups, prescription/shipping updates, refill notices, renewal/billing notices, and support replies. By providing your number at signup and confirming service SMS, you consent under the TCPA for Sipra and our service providers to send these messages, including via autodialer or prerecorded voice, at the number provided. Some are required for safe care and continuous fulfillment; if you opt out of all SMS, we continue essential clinical and billing information by email or another channel.

(b) Marketing SMS, separate, opt-in only. Promotional offers, new-product announcements, and educational content unrelated to active care. Consent is via a separate unchecked checkbox at signup, distinct from transactional consent. Service use without marketing consent is allowed; marketing consent is never a condition of any purchase, evaluation, or prescription.

Reply STOP to opt out at that number. Reply HELP for help. After marketing opt-out, transactional messages in (a) may still be sent. Frequency: Up to 8 messages per month. Message and data rates may apply.

Program: Sipra account and promotional alerts. For help, reply HELP or contact [email protected].

Use of communications information is described in our Privacy Policy and HIPAA Notice of Privacy Practices. Marketing channels never carry PHI. Clinical messages stay in the patient portal with transport encryption (TLS 1.2+) and at-rest encryption (AES-256).

We do not record asynchronous intakes. If a live consult is recorded for clinical or quality purposes, your physician will tell you and request consent first. You can decline without affecting your care.

Important emails (renewal reminders, cancellation confirmations, refund notices) come from sipra.com domains. Add [email protected] to your contacts. We are not responsible for emails marked as spam or blocked by your provider; we are responsible for sending on time to the address on file.

• Intake parsing. AI organizes answers into a summary; the physician reviews the underlying answers, not just the summary.
• Triage. AI flags possible urgency, contraindication, or red-flag symptoms; a clinician decides.
• Customer-service routing. AI routes your message to the right team and may suggest a draft a human reviews/edits before sending.
• Fraud detection. AI flags signs of identity fraud, payment fraud, or medication diversion. Humans act on flags.

AI does not:

• decide whether to prescribe;
• decide a dose;
• change a treatment plan;
• decide Service eligibility; or
• respond to clinical questions without a human clinician's review.

Request human review of any decision affecting your care or account by emailing [email protected]. We route requests to a human promptly.

All Sipra software, designs, logos, copy, photos, graphics, and other materials are owned by Sipra or our licensors and protected by U.S. and international IP laws. The sipra trademarks and leaf mark are Sipra's. Other product names and trademarks belong to their owners.

Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to use the Service for personal, non-commercial healthcare needs. You may not copy, sell, redistribute, scrape, reverse-engineer, or build a competing service.

Sipra does not claim a blanket license over your content. Testimonials, photos, videos, or quotes are used only as described in a separate written consent you sign before that use:

• Testimonials/photos: used only with separate written consent naming channel and duration. You can revoke consent any time on a forward-looking basis.
• Feedback: feedback about the Service is non-confidential; we may use it to improve the Service without compensation. Feedback is not PHI.

Sipra complies with the FTC Endorsement Guides. Testimonials are from real, consenting patients. Material connections (compensation, gifts) are disclosed in plain language. Sponsored content uses #ad or #sponsored in the first line.

If you believe content on the Service infringes your copyright, send written notice to:

Copyright Agent, c/o Sipra LLC, 30 N Gould St, Ste R, Sheridan, WY 82801, [email protected] (registration with the U.S. Copyright Office to be completed prior to launch)

Include the six elements required by 17 USC §512(c)(3): physical or electronic signature; identification of the copyrighted work; identification of the infringing material with enough detail to locate; your contact information; a good-faith statement that the use is not authorized; and a statement under penalty of perjury that the notice is accurate and you are authorized to act for the owner. Repeat infringers' accounts will be terminated.

Where the Service hosts user-submitted content, Sipra is an interactive computer service provider under Section 230. We are not the publisher or speaker of user-submitted content and may remove content at our discretion.

Sipra and the affiliated medical practice comply with the HIPAA reproductive health rule effective February 26, 2026. We do not disclose PHI about reproductive care for use in any investigation against, or to impose liability on, a person for seeking, obtaining, providing, or facilitating lawful reproductive health care, except as HIPAA permits or requires.

Sipra does not fire third-party advertising pixels (Meta Pixel, TikTok Pixel, Google Analytics, etc.) on intake or quiz pages without prior opt-in. Cookie/tracker disclosures are in the Privacy Policy and cookie banner.

Because the Service is cash-pay only, you have paid in full out of pocket. Under HIPAA, you can ask the affiliated medical practice to restrict disclosure of treatment information to any health plan. Email [email protected] to request.

Any claim arising out of these Terms or the Service must be filed within 1 year of accrual, or it is permanently barred. This does not apply to (a) California residents (Section 21.3), (b) New Jersey residents (Section 21.5), or (c) residents of any state where this limit is unenforceable; those residents retain the statutory limitations period.

California residents who sign a release of claims to Sipra waive Cal. Civ. Code §1542, which states: "A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party." Residents of states with similar statutes waive those too.

If you see another user violating these Terms, impersonation, medication-sharing, or fraudulent intake, report it to [email protected]. We will investigate promptly and act when warranted.

Each account is for one person. You may not let another person sign in under your credentials, complete intake as you, or otherwise impersonate you. Doing so can lead to inappropriate prescribing and serious harm.

Reselling, transferring, or distributing prescription medication issued in your name is a federal crime under 21 USC §§841 and 844 and may violate state law. Sipra cooperates with law-enforcement subpoenas on prescription diversion.

These rules cover all disputes between you and Sipra arising from or relating to the Service or these Terms (advertising, billing, privacy, termination), but not IP-infringement claims (brought in court).

Before filing arbitration, send a written Pre-Arbitration Demand to [email protected] with your name, account email, dispute description, requested relief, and signature. We may request a 30-minute videoconference within 60 days. The 60-day period tolls any statute of limitations. You may not file arbitration before the 60-day period ends.

These Terms involve interstate commerce. The FAA (9 USC §1 et seq.) governs interpretation and enforcement of this Section. Either party can ask a court to compel arbitration if the other tries to avoid it.

You can opt out of arbitration. Email [email protected] within 30 days of first acceptance with subject "Arbitration Opt-Out" and your full name, account email, and residential address. Opting out does not affect other Terms. The 30 days run from your first individual acceptance, not any historical date.

Arbitration is administered by National Arbitration and Mediation (NAM) under its Comprehensive Dispute Resolution Rules and, where applicable, Mass Arbitration Supplemental Rules. Fee schedule: NAM Comprehensive Dispute Resolution Rules and Procedures fee schedule (or NAM Consumer Arbitration Rules where the dispute is consumer-facing). Sipra pays NAM filing and administrative fees beyond what you would pay in court, except as the arbitrator allocates for frivolous filings.

ARBITRATION IS INDIVIDUAL ONLY. YOU AND SIPRA AGREE NOT TO BRING A CLAIM AS A PLAINTIFF OR CLASS MEMBER IN ANY CLASS, COLLECTIVE, REPRESENTATIVE, OR PRIVATE ATTORNEY GENERAL PROCEEDING, AND THE ARBITRATOR CANNOT CONSOLIDATE CLAIMS OR ORDER CLASS RELIEF. If a court holds the class action waiver unenforceable for a claim, that claim must be litigated in court, the rest of this Section stays in force.

If 25+ similar arbitration demands are filed against Sipra by the same or coordinated counsel within 60 days, they are batched in groups of up to 100. Each batch gets a single arbitrator hearing bellwether cases first; remaining cases tolled. Filing and administrative fees for batched cases are consolidated. The parties will work in good faith on an early-resolution framework before bellwether hearings.

The arbitrator can grant the same individual relief a court could (money damages, declaratory and injunctive relief specific to the individual claim), but no class-wide or representative relief.

YOU AND SIPRA EACH WAIVE ANY RIGHT TO A JURY TRIAL.

If any part of this Section is held unenforceable, the rest applies to the maximum extent allowed by law. The class action waiver is not severable from the agreement to arbitrate; if found unenforceable, the entire Section 19 is unenforceable for that claim, and the claim proceeds in the courts in Section 20.1.

These Terms are governed by the laws of Wyoming, without regard to conflict-of-laws rules. For claims that cannot be arbitrated, the parties consent to exclusive jurisdiction of the state and federal courts in Delaware.

These Terms, with the Privacy Policy, HIPAA Notice of Privacy Practices, Telehealth and Medication Consent, Refund Policy, Consumer Health Data Privacy Policy, ISI, and any product- or state-specific addenda referenced here, are the entire agreement between you and Sipra about the Service. If these Terms conflict with a referenced policy, these Terms control unless the policy expressly says it controls on its subject matter.

If any part of these Terms is unenforceable, that part is modified to the minimum needed to make it enforceable; the rest stays in effect.

You cannot assign without our written consent. We can assign to an affiliate or successor in a merger, acquisition, or asset sale.

Failing to enforce a provision is not a waiver of the right to enforce it later.

These sections survive termination: 4, 5, 6.10, 10, 11, 13, 14, 15, 16, 17, 19, 20, 21, and 22.

Sipra is not liable for failure or delay from events beyond our reasonable control, natural disasters, pandemics, public health emergencies, war, terrorism, government action, drug-supply disruption, FDA action, internet/utility outages, labor disputes, or third-party vendor failures. We use reasonable efforts to resume promptly.

We send legal notices by email to the address on your account. Send legal notices to us at [email protected] or by mail to 30 N Gould St, Ste R, Sheridan, WY 82801.

If you access the Service through an Apple App Store or Google Play app, the platform's standard EULA applies between you and the platform. Apple and Google are not parties to these Terms and have no obligation to support the Service.

Headings are for convenience. "Including" means "including, without limitation." Singulars include plurals.

California residents can reach the Complaint Assistance Unit of the Division of Consumer Services of the California Department of Consumer Affairs in writing at 1625 North Market Blvd., Suite N 112, Sacramento, CA 95834, or by telephone at 1-800-952-5210.

California residents: your subscription auto-renews; renewal price, frequency, and one-click cancellation are disclosed before each renewal. Cancel via patient portal or [email protected].

California residents are not subject to the 1-year contractual statute of limitations in Section 14.1 and retain the full statutory limitations period under California law.

If you are a Florida resident and your treatment includes a weight-loss program, you have these rights:

(a) Weight loss is influenced by many factors, genetic/metabolic differences, eating habits, exercise, motivation, adherence; (b) rapid weight loss can cause serious health risks; (c) consult a physician before starting any weight-loss program; (d) only permanent lifestyle changes, healthy diet and regular physical activity, promote long-term weight loss; (e) staff qualifications/credentials are available on request; (f) you can request an advance price list and itemized charges; and (g) you can cancel any time; the refund schedule is in the Refund Policy.

Effective June 20, 2026; presented in 24-point boldface at enrollment for Florida residents as required by §501.0575.

New Jersey residents: nothing limits Sipra's liability for negligent or intentional conduct beyond what New Jersey law allows; the 1-year limit in Section 14.1 does not apply.

Washington, Nevada, and Connecticut residents have additional consumer-health-data rights under the Washington My Health My Data Act (Ch. 19.373 RCW), Nevada Consumer Health Data Privacy Law (NRS Ch. 603A.500-.595), and Connecticut Data Privacy Act (Conn. Gen. Stat. §42-515 et seq.), described in the https://sipra.com/health-data-privacy.

Residents of those states have additional rights under applicable state consumer-privacy law, rights to know, delete, correct, opt out of targeted advertising and sale, and appeal denials, described in the https://sipra.com/privacy.

Auto-renewal terms are also subject to: New York GBL §527-a; Massachusetts 940 CMR; Oregon HB 4032; Connecticut Conn. Gen. Stat. §42-126b; Illinois 815 ILCS 601; North Carolina N.C. Gen. Stat. §75-41; Vermont 9 V.S.A. §2455; Hawaii HRS §481-9.5; Maine 10 M.R.S. §1210-B; New Mexico N.M. Stat. §57-12-25; Rhode Island R.I. Gen. Laws §6-13-14; Wisconsin Wis. Stat. §100.205; and D.C. Code §28-3905. Where state law gives you greater rights, that law applies.

Patients residing in New York and New Jersey have the right under their respective state patient billing laws to request an itemized price list from Sipra for their laboratory tests.

For this document or any Service feature in alternative format, email [email protected] or [email protected]. Commitments: https://sipra.com/accessibility.

If we cannot resolve a complaint, you can file with:

• FTC at reportfraud.ftc.gov;
• HHS Office for Civil Rights at [email protected] (HIPAA matters);
• your state attorney general's consumer-protection division;
• California residents, Complaint Assistance Unit (Section 21.1); and
• Washington residents, Washington AG at https://www.atg.wa.gov/file-complaint (consumer-health-data matters).

We stay with you. Questions, complaints, or feedback are welcome at the contacts above.